A study to evaluate the consistency of oscillometry and spirometry test results in patients with confirmed or suspected asthma or COPD

Trial Identifier: D589BR00078
Sponsor: AstraZeneca
Start Date: February 2024
Primary Completion Date: August 2024
Study Completion Date: August 2024

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
China Beijing, China
China Changsha, China
China Chengdu, China
China Chongqing, China
China Dalian, China
China Erdos, China
China Fengcheng, China
China Fuyang, China
China Fuzhou, China
China Guangzhou, China
China Guiyang, China
China Haikou, China
China Hanchuan, China
China Hangzhou, China
China Haozhou, China
China Henan, China
China Hong Kong, China
China Jinan, China
China Jingzhou, China
China Kunming, China
China Mianyang, China
China Nanchang, China
China Nantong, China
China Ningbo, China
China Panzhou, China
China Qionghai, China
China Shanghai, China
China Shenyang, China
China Shenzhen, China
China Suining, China
China Suzhou, China
China Taiyuan, China
China Taizhou, China
China Tianjin, China
China Xinyang, China
China Yulin, China
China Yunnan, China
China Zhaotong, China
China Zhengzhou, China
China Zhuji, China
China Zigong, China